Charlie Hospital Semarang Tbk. vs Semen Baturaja Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Semen Baturaja Tbk. trades at Rp164 (market cap 1.56T, 7.56M 24h volume). The key difference: Semen Baturaja Tbk. is far larger — about 2.1× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 7.56M). Which is the better fit depends on your goals.
| RSCH | SMBR | |
|---|---|---|
Market Cap | 742B | 1.56T |
Volume | 29.45M | 7.56M |
Lot | 294.49K | 75.59K |
Turnover | 8.14B | 1.23B |
Average Price | 276.35 | 163.33 |
Value | 8.14B | 1.23B |
Indicative Equilibrium Price | 270 | 164 |
Indicative Equilibrium Volume | 103 | 254 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Read more on SMBR →